by Brandon Tudor | Nov 24, 2025 | Blog
Dated 11/23/2025, the article published in Cureus titled “Defining ‘Normal’ Liver Function Tests” is worth a careful read–“Chronic liver disease often remains undiagnosed until cirrhosis develops, with standard liver function tests (LFTs)...
by Brandon Tudor | Nov 13, 2025 | Uncategorized
5 Takeways from The Liver Meeting (AASLD) in DC – November 2025 1]. Bloodwork is becoming more discerning in liver disease, e.g., Helio Genomics in HCC. 2]. New modalities are on the rise around the Liver MRI, e.g., Resoundant and Perspectum.3]. Because of the...
by Brandon Tudor | Nov 6, 2025 | Uncategorized
Brandon Tudor, Dr. Al Lalos and Pete Celano of LiverRight hope to see you this week in DC at the AASLD meeting. What’s the most prevalent yet undiagnosed specialty condition, that is VERY straightforward to diagnose and treat, and its early stages (F1 and F2)...
by Brandon Tudor | Nov 2, 2025 | Uncategorized
Here’s a detailed summary of “Entering Our Fourth Decade: The Next Chapter of Liver Transplantation” by Andrés Cárdenas and Timuçin Taner, dated October 28, 2025. Overview This editorial marks the beginning of the authors’ tenure as Editors-in-Chief of Liver...
by Brandon Tudor | Oct 28, 2025 | Uncategorized
The November 2025 article published in The Journal of Hepatology and titled “Non-invasive tests for MetALD and alcohol-related liver disease” is summarized in what follows, and makes these key points– — Non-invasive tests are available and...